Potential of drug-loaded nanoparticles for Alzheimers disease: Diagnosis, prevention and treatment

Therapeutic Delivery

Volumn 3, Issue 9, 2012, Pages 1025-1027

  Doggui, Sihem ^a,b   Dao, Lé ^b   Ramassamy, Charles ^a,c  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b INRS EMT   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

amyloid; antioxidant; curcumin; drug delivery; encapsulation; nanoparticles; neurodegenerative diseases

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CHITOSAN; CHOLINESTERASE INHIBITOR; CURCUMIN; ENBUCRILATE; FREE RADICAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NANOPARTICLE; POLYGLACTIN; POLYPHENOL; POLYSORBATE 80; RIVASTIGMINE; TACRINE; TAU PROTEIN; THIOFLAVINE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BIOCOMPATIBILITY; BIODEGRADABILITY; BLOOD BRAIN BARRIER; DRUG ABSORPTION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; DRUG TARGETING; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HUMAN; NANOENCAPSULATION; NANOTECHNOLOGY; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 84865759229     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.84     Document Type: Review

References (13)

1. Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503), 2112-2117 (2005). (Pubitemid 41797645)
2. Kukull WA, Higdon R, Bowen JD et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 59(11), 1737-1746 (2002). (Pubitemid 35340484)
3. Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C. Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J. Control. Release 152(2), 208-231 (2011).
4. Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly (n-butylcyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 70(1), 75-84 (2008).
5. Wilson B, Samanta MK, Santhi K, Kumar KP, Ramasamy M, Suresh B. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 6(1), 144-152 (2010).
6. Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Poly (n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res. 1200, 159-168 (2008).
7. Siegemund T, Paulke BR, Schmiedel H et al. Thioflavins released from nanoparticles target fibrillar amyloid beta in the hippocampus of APP/PS1 transgenic mice. Int. J. Dev. Neurosci. 24(2-3), 195-201 (2006).
8. Singh M, Arseneault M, Sanderson T, Murthy V, Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 56(13), 4855-4873 (2008). (Pubitemid 352039080)
9. Belkacemi A, Doggui S, Dao L, Ramassamy C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev. Mol. Med. 13, e34 (2011).
10. Doggui S, Sahni JK, Arseneault M, Dao L, Ramassamy C. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J. Alzheimers Dis. 30(2), 377-392 (2012).
11. Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int. J. Pharm. 416(1), 331-338 (2011).
12. Khumsupan P, Ramirez R, Khumsupan D, Narayanaswami V. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochim. Biophys. Acta. 1808(1), 352-359 (2011).
13. Mathew A, Fukuda T, Nagaoka Y et al. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease. PLoS ONE 7(3), e32616 (2012).